- Jun 30th, 2023
Floaters and Eye Flashes: Are They Harmless or Cause for Concern?
Have you noticed shapes drifting across your field of vision, or brief strikes of lightning? You may be afflicted with floaters or eye flashes, which typically are symptoms of other conditions.
- Jun 30th, 2023
Top 5 Risk Factors for Age-Related Macular Degeneration
If you’re 50 years or older, you’re probably familiar with age-related macular degeneration (AMD). While you can’t avoid the passage of time, some risk factors can be effectively managed.
- May 31st, 2023
Quiz: How Much Do You Know About the Retina?
The retina is one of the eye's most essential components. How much do you really know about it, though? here's a brief quiz to test your retinal recall.
- May 26th, 2023
Coping with Visual Impairments: Tips for Maintaining Positive Mental Health
Vision loss’ impact on mental and emotional health can be devastating, leading to social isolation and depression. Following certain lifestyle changes can help you stay positive.
- May 12th, 2023
Dr. Shields Presents Geographic Atrophy CE Event
Thank you to all of our doctors who attended our continuing education symposium, “Geographic Atrophy in Modern Clinical Practice” on April 19th.
- Apr 27th, 2023
Reasons You May be Referred to a Retina Specialist
Should your ophthalmologist need outside assistance, you may be referred to a retina specialist - specially trained eye doctors who treat disorders of the retina, macula, and vitreous.
- Apr 3rd, 2023
FDA Approves New Medication for Geographic Atrophy
The FDA has approved Syfovre™, the first and only treatment for geographic atrophy. A damaging, blinding, final phase of dry AMD, it afflicts over 1 million Americans.
- Mar 31st, 2023
Drug Toxicity & Retinal Health: What You Should Know
Before taking a new medication, you should be careful, as certain drugs may be toxic to the retina.
- Mar 28th, 2023
The First Ever Treatment for Geographic Atrophy Is Now Available
There's amazing news for the more than one million Americans afflicted with geographic atrophy-Syfovre™ (pegcetacoplan injection) was recently approved by the US Food and Drug Administration (FDA).
- Feb 17th, 2023
Dry Age-Related Macular Degeneration & Geographic Atrophy
Geographic atrophy is responsible for approximately 20% of all legal blindness related to age-related macular degeneration (AMD). Learn more about dry AMD & geographic atrophy.
A Team of Experts: Experience You Can Trust